M
Maria Ho
Researcher at National Comprehensive Cancer Network
Publications - 18
Citations - 2724
Maria Ho is an academic researcher from National Comprehensive Cancer Network. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 15, co-authored 17 publications receiving 2595 citations. Previous affiliations of Maria Ho include BC Cancer Agency & University of British Columbia.
Papers
More filters
Journal ArticleDOI
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
TL;DR: Findings indicate that SP is an enriched source of lung tumor-initiating cells with stem cell properties and may be an important target for effective therapy and a useful tool to investigate the tumorigenic process.
Journal ArticleDOI
Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology
James L. Mohler,Philip W. Kantoff,Andrew J. Armstrong,Robert R. Bahnson,Michael B. Cohen,Anthony V. D'Amico,James A. Eastham,Charles Arthur Enke,Thomas A. Farrington,Celestia S. Higano,Eric M. Horwitz,Christopher J. Kane,Mark H. Kawachi,Michael Kuettel,Timothy M. Kuzel,Richard T. Lee,Arnold W. Malcolm,David Miller,Elizabeth R. Plimack,Julio M. Pow-Sang,David Raben,Sylvia Richey,Mack Roach,Eric M. Rohren,Stan Rosenfeld,Edward M. Schaeffer,Eric J. Small,Guru Sonpavde,Sandy Srinivas,Cy A. Stein,Seth A. Strope,Jonathan D. Tward,Dorothy A. Shead,Maria Ho +33 more
TL;DR: Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations.
Journal ArticleDOI
Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines
James L. Mohler,Andrew J. Armstrong,Robert R. Bahnson,Barry Boston,J. Erik Busby,Anthony V. D'Amico,James A. Eastham,Charles Arthur Enke,Thomas A. Farrington,Celestia S. Higano,Eric M. Horwitz,Philip W. Kantoff,Mark H. Kawachi,Michael Kuettel,Richard T. Lee,Gary R. MacVicar,Arnold W. Malcolm,David Miller,Elizabeth R. Plimack,Julio M. Pow-Sang,Mack Roach,Eric M. Rohren,Stan Rosenfeld,Sandy Srinivas,Seth A. Strope,Jonathan D. Tward,Przemyslaw Twardowski,Patrick C. Walsh,Maria Ho,Dorothy A. Shead +29 more
TL;DR: Abiraterone acetate is a first-in-class hormonal agent that represents a new standard of care for patients with metastatic castration-recurrent prostate cancer who have previously received docetaxel (category 1 recommendation).
Journal ArticleDOI
NCCN Task Force Report: Management of Neuropathy in Cancer
Michael D. Stubblefield,Harold J. Burstein,Allen W. Burton,Christian M. Custodio,Gary E. Deng,Maria Ho,Larry Junck,G. Stephen Morris,Judith A. Paice,Sudhakar Tummala,Jamie H. Von Roenn +10 more
TL;DR: This report documents the proceedings of this meeting with a general background on neuropathy and neuropathy in oncology, followed by discussions on challenges and research issues, evaluation criteria, and management of different symptoms associated with this disorder.
Journal ArticleDOI
Myeloid Growth Factors
Jeffrey Crawford,James Olen Armitage,Lodovico Balducci,Pamela S. Becker,Douglas W. Blayney,Spero R. Cataland,Mark L. Heaney,Susan Hudock,Dwight D. Kloth,David J. Kuter,Gary H. Lyman,Brandon McMahon,Hope S. Rugo,Ayman Saad,Lee S. Schwartzberg,Sepideh Shayani,David P. Steensma,Mahsa Talbott,Saroj Vadhan-Raj,Peter Westervelt,Michael Westmoreland,Mary A. Dwyer,Maria Ho +22 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for Myeloid Growth Factors provide recommendations on the use of these agents mainly in the oncology setting based on clinical evidence and expert consensus and includes revisions surrounding the issue of timing of pegfilgrastim administration.